Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last SFr.18.97 CHF
Change Today -0.16 / -0.84%
Volume 428.0K
CLN On Other Exchanges
Symbol
Exchange
OTC US
OTC US
SIX Swiss Ex
Frankfurt
As of 7:49 AM 07/7/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for clariant ag-reg (CLN)

Year over year, Clariant AG has seen revenues remain relatively flat (SFr.6.1B CHF to SFr.6.1B CHF), though the company was able to grow net income from SFr.20.0M CHF to SFr.152.0M CHF. A reduction in the percentage of sales devoted to cost of goods sold from 71.30% to 71.03% was a key component in the bottom line growth in the face of flat revenues.
View Income Statement In U.S. Dollar
Currency in
Millions of Swiss Francs
As of:Dec 31
2011
Restated
CHF
Dec 31
2012
Restated
CHF
Dec 31
2013
Restated
CHF
Dec 31
2014
CHF
4 Year
Trend
Revenues5,571.06,038.06,076.06,116.0
TOTAL REVENUES5,571.06,038.06,076.06,116.0
Cost of Goods Sold3,983.04,288.04,332.04,344.0
GROSS PROFIT1,588.01,750.01,744.01,772.0
Selling General & Admin Expenses, Total844.01,077.01,049.01,049.0
R&D Expenses140.0175.0199.0213.0
OTHER OPERATING EXPENSES, TOTAL984.01,252.01,248.01,262.0
OPERATING INCOME604.0498.0496.0510.0
Interest Expense-159.0-198.0-139.0-160.0
Interest and Investment Income14.017.011.011.0
NET INTEREST EXPENSE-145.0-181.0-128.0-149.0
Income (Loss) on Equity Investments46.048.063.075.0
Other Non-Operating Income (Expenses)5.05.03.03.0
EBT, EXCLUDING UNUSUAL ITEMS510.0370.0434.0439.0
Merger & Restructuring Charges-223.0-139.0-123.0-228.0
Impairment of Goodwill----15.0--
Gain (Loss) on Sale of Assets5.04.019.0168.0
EBT, INCLUDING UNUSUAL ITEMS292.0235.0345.0379.0
Income Tax Expense72.032.022.0144.0
Minority Interest in Earnings-17.0-13.0-17.0-60.0
Earnings from Continuing Operations220.0203.0323.0235.0
EARNINGS FROM DISCOUNTINUED OPERATIONS24.017.0-326.0-23.0
NET INCOME227.0207.0-20.0152.0
NET INCOME TO COMMON INCLUDING EXTRA ITEMS227.0207.0-20.0152.0
NET INCOME TO COMMON EXCLUDING EXTRA ITEMS203.0190.0306.0175.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CLN:VX SFr.18.97 CHF -0.16

CLN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Arkema SA €62.94 EUR -0.75
Ashland Inc $120.98 USD -0.93
Lonza Group AG SFr.128.70 CHF +1.50
Valspar Corp/The $82.62 USD -0.20
Wacker Chemie AG €91.75 EUR -1.45
View Industry Companies
 

Industry Analysis

CLN

Industry Average

Valuation CLN Industry Range
Price/Earnings 21.4x
Price/Sales 1.0x
Price/Book 2.8x
Price/Cash Flow 23.0x
TEV/Sales 0.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CLARIANT AG-REG, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.